Pfizer recently reported strong earnings for the third quarter, surpassing Wall Street expectations. As a result, the company has increased […]
AbbVie has agreed to buy Aliada Therapeutics for $1.4 billion. This deal includes Aliada’s main product, ALIA-1758, which is being
The UK government and its drug regulator have issued a warning about the misuse of certain weight-loss medications. These drugs,
A recent trial found that nearly 60% of patients with a rare condition called eosinophilic granulomatosis with polyangiitis (EGPA) went
Pfizer and the American Cancer Society (ACS) have teamed up with actor Patrick Dempsey to spotlight healthcare access issues that
At the Outsourcing in Clinical Trials Conference in New England, the US Customs and Border Protection (CBP) highlighted common legal
Parabilis Medicines, previously known as FogPharma, is a biotech company that has changed its name to better reflect its mission.
Novartis and Apellis Pharmaceuticals are competing to develop treatments for a rare kidney disease. Both companies recently shared promising results
MVA-BN, a vaccine for mpox (monkeypox) and smallpox, is sold under the name Jynneos in the US and Imvanex in
The US is considering approving VTAMA cream, a treatment for skin conditions, for atopic dermatitis. Organon has bought Dermavant Sciences,
